ZNF330circle142141735-142142329 was significantly amplified in PRAD, and ZNF330 was also consistently highly expressed in PRAD Whereas, PITPNM3circle6458635-6459156 was upregulated in PRAD, but PITPNM3 was lowly expressed in PRAD. Here, PITPNM3 is linked to prostate adenocarcinoma.